[ASND] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
19-May-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- 35.25%
YoY- 11.66%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 372 1,043 1,169 1,136 1,258 1,977 2,117 -68.59%
PBT -25,153 -16,426 -18,311 -13,359 -20,636 -12,249 -7,470 124.48%
Tax -14 22 -57 -74 -118 -254 -160 -80.26%
NP -25,139 -16,448 -18,254 -13,285 -20,518 -11,995 -7,310 127.66%
Tax Rate - - - - - - - -
Total Cost 25,511 17,491 19,423 14,421 21,776 13,972 9,427 94.07%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin -6,757.80 -1,576.99 -1,561.51 -1,169.45 -1,631.00 -606.73 -345.30 624.91%
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS -0.78 -0.51 -0.72 -0.53 -0.82 -0.48 -0.30 88.97%
EPS Diluted -0.78 -0.51 -0.72 -0.53 -0.82 -0.48 -0.30 88.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.